Form 8-K - Current report:
SEC Accession No. 0001193125-21-069772
Filing Date
2021-03-04
Accepted
2021-03-04 17:27:10
Documents
14
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147672d8k.htm   iXBRL 8-K 25660
2 EX-99.1 d147672dex991.htm EX-99.1 63674
6 GRAPHIC g147672snap0004.jpg GRAPHIC 8929
  Complete submission text file 0001193125-21-069772.txt   232747

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210304.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210304_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210304_pre.xml EX-101.PRE 11428
7 EXTRACTED XBRL INSTANCE DOCUMENT d147672d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21715433
SIC: 2834 Pharmaceutical Preparations